Literature DB >> 34139388

Biobehavioral Research and Hematopoietic Stem Cell Transplantation: Expert Review from the Biobehavioral Research Special Interest Group of the American Society for Transplantation and Cellular Therapy.

Debra Lynch Kelly1, Karen Syrjala2, Mallory Taylor3, Kelly E Rentscher4, Shahrukh Hashmi5, William A Wood6, Heather Jim7, Anna Barata7, Kathryn E Flynn8, Linda J Burns9, Bronwen E Shaw10, Effie Petersdorf11, Anela Carrazana Yero12, Amanda D Emmrich13, Keayra E Morris14, Erin S Costanzo15, Jennifer M Knight16.   

Abstract

Hematopoietic cell transplantation (HCT) is a potentially curative treatment for many hematologic conditions. Despite advances in conditioning and supportive measures, however, there remain significant comorbidities that threaten survivorship. Adverse effects of stress-related biobehavioral processes-defined here as the interactions of behavioral, psychological, and socioenvironmental factors with biology-impact immune recovery and function and are particularly salient in the HCT context, given the importance of immune reconstitution for improved survivorship. However, biobehavioral processes have been underinvestigated in this vulnerable group compared with other cancer populations. Here the Biobehavioral Research Special Interest Group (SIG) of the American Society for Transplantation and Cellular Therapy provides an expert review to inform research directions explicating the biological correlates of behavioral symptoms and evaluate the impact of these on HCT outcomes. The goal of this expert review is to provide a foundation for advancing science that effectively integrates behavioral and biological processes to optimize quality of life and improve clinical outcomes for HCT recipients.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Biobehavioral; hematopoietic cell transplantation; outcomes; stress; survivorship

Year:  2021        PMID: 34139388     DOI: 10.1016/j.jtct.2021.06.007

Source DB:  PubMed          Journal:  Transplant Cell Ther        ISSN: 2666-6367


  3 in total

Review 1.  Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy Recipients.

Authors:  Jennifer M Knight; Mallory R Taylor; Kelly E Rentscher; Elisabeth C Henley; Hannah A Uttley; Ashley M Nelson; Lucie M Turcotte; Natalie S McAndrew; Hermioni L Amonoo; Lathika Mohanraj; Debra Lynch Kelly; Erin S Costanzo
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

2.  The effect of tocilizumab on patient reported outcomes and inflammatory biomarkers in hematopoietic cell transplantation.

Authors:  Mallory R Taylor; Cecilia J Hillard; William R Drobyski; Aniko Szabo; Bryon D Johnson; Fenlu Zhu; Charles L Raison; Steve W Cole; Jennifer M Knight
Journal:  Brain Behav Immun Health       Date:  2022-06-11

3.  Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy.

Authors:  Cecilia J Hillard; Nirav N Shah; Jennifer M Knight; Aniko Szabo; Igli Arapi; Ruizhe Wu; Amanda Emmrich; Edward Hackett; Garrett Sauber; Sharon Yim; Bryon Johnson; Parameswaran Hari; Dina Schneider; Boro Dropulic; Rachel N Cusatis; Steve W Cole
Journal:  Commun Med (Lond)       Date:  2022-05-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.